Company profile for LifeMine Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LifeMine is the first company to massively scale the genomic discovery of powerful new drug modalities from eukaryotic microbes. Our integrated, genomically-enabled drug discovery engine is poised to deliver a pipeline of medicines that will conquer previously unconquerable human diseases. The company has succeeded in hacking an evolutionary code in biosynthetic genes, creating a springboard for rapid discovery of naturally i...
LifeMine is the first company to massively scale the genomic discovery of powerful new drug modalities from eukaryotic microbes. Our integrated, genomically-enabled drug discovery engine is poised to deliver a pipeline of medicines that will conquer previously unconquerable human diseases. The company has succeeded in hacking an evolutionary code in biosynthetic genes, creating a springboard for rapid discovery of naturally inspired drugs that function in unexpected ways. These medicines transcend the standard playbook of drug design.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Cambridge Discovery Park 30 Acorn Park Drive Cambridge, MA 02140
Telephone
Telephone
617.665.5000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250407523884/en/LifeMine-Announces-First-Participant-Dosed-in-First-in-human-Phase-1-Clinical-Trial-of-LIFE-001-Designed-De-Novo-to-Become-a-Field-Dominating-Immunosuppressive-for-Immune-mediated-Disorders-and-Transplantation

BUSINESSWIRE
08 Apr 2025

https://www.fiercebiotech.com/biotech/lifemine-therapeutics-lays-staff-pivots-away-rd-drill-lead-asset-clinic

FIERCE BIOTECH
31 Mar 2025

https://www.businesswire.com/news/home/20221204005044/en/LifeMine-Therapeutics-Appoints-Elliot-Ehrich-M.D.-as-Chief-Medical-Officer-and-EVP-of-Translational-Science-and-Lata-Jayaraman-Ph.D.-as-EVP-and-Head-of-Biology

BUSINESSWIRE
05 Dec 2022

https://www.businesswire.com/news/home/20221013005143/en

BUSINESSWIRE
13 Oct 2022

https://www.businesswire.com/news/home/20221006005183/en

BUSINESSWIRE
06 Oct 2022
LifeMine locks down $70M 'dream scenario' fungi deal with GSK
LifeMine locks down $70M 'dream scenario' fungi deal with GSK

24 Mar 2022

// A. Armstrong FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/lifemine-locks-down-70m-dream-scenario-gsk-fungi-partnership-and-fundraising-too

A. Armstrong FIERCEBIOTECH
24 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty